No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
120 |
4. Check minimum number of eventsNone |
120 |
5. Include endpointsNone |
120 |
6. Filter based on genotype QC (FinnGen only) |
118 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Interstitial cystitis (chronic), drug-induced
based on the number of shared cases.
Similar with more cases:
- Cystitis
- Other diseases of urinary system
- Genitourinary diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 118 | 105 | 13 |
| Unadjusted period prevalence (%) | 0.03 | 0.04 | 0.01 |
| Median age at first event (years) | 50.13 | 49.94 | 51.65 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 120
- Matched controls
- 1200
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
+∞
161.1
120
8
UKC02
NOMESCO Finland
Cystoscopy
34.3
88.8
88
89
KCV04
NOMESCO Finland
Distension of bladder with fluid
507.6
85.7
76
*
G04BD07
ATC
tolterodine; oral
17.5
49.7
50
47
G04BD04
ATC
oxybutynin; oral, transdermal
15.5
49.7
57
66
5951A
ICD-9 Finland
Cystitis, Chronic interstitial cystitis
+∞
34.0
31
*
7325
FHL
Bladder stretching
+∞
31.7
29
*
XKD00
NOMESCO Finland
Uroflowmetry
10.2
29.6
41
58
R35
ICD-10 Finland
Polyuria
10.0
24.7
33
44
59504
ICD-8 Finland
Cystitis, Interstitialis (Hunner)
237.6
20.2
20
*
1530
FHL
Urethrocystoscopy
46.8
19.4
23
6
TKD00
NOMESCO Finland
Dilatation of urethra
111.9
18.1
19
*
N30.0
ICD-10 Finland
Acute cystitis
5.2
16.8
49
141
J01MA06
ATC
norfloxacin; oral
4.8
15.1
49
152
ZX136
NOMESCO Finland
Intravesicalis
91.6
15.0
16
*
J01EA01
ATC
trimethoprim; systemic
4.4
14.4
70
292
N06CA01
ATC
amitriptyline and psycholeptics; systemic
5.4
14.1
34
82
G04BD
ATC
Drugs for urinary frequency and incontinence
157.0
13.8
14
*
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
45.6
13.5
16
*
KCV02
NOMESCO Finland
Cystoscopic balloon distension of bladder
+∞
11.6
11
*
N30.9
ICD-10 Finland
Cystitis, unspecified
5.4
11.6
26
58
L04AA01
ATC
[U] ciclosporin
28.3
11.5
15
6
N02AX02
ATC
tramadol; systemic, rectal
3.7
10.9
75
376
7321
FHL
TU biopsy, coagulation or laser
+∞
10.6
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
5.5
10.2
22
47
J01MA02
ATC
ciprofloxacin; systemic
3.4
9.9
72
367
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
5.1
9.8
23
53
P01BA02
ATC
hydroxychloroquine; oral
4.5
9.7
27
72
G04AC01, ,
ATC
9.0
9.6
20
26
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.3
9.5
64
309
UJF32
NOMESCO Finland
Coloscopy
3.4
9.4
51
216
R30.0
ICD-10 Finland
Dysuria
9.2
9.3
19
24
R30.1
ICD-10 Finland
Vesical tenesmus
20.6
9.2
13
7
G04BD01
ATC
emepronium; systemic
20.6
9.2
13
7
A03FA02
ATC
cisapride; oral, rectal
4.7
8.8
23
58
J01MA01
ATC
ofloxacin; systemic
4.5
8.7
24
63
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
8.6
57
269
N06AA09
ATC
amitriptyline; systemic
4.1
8.4
27
80
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
24.0
8.2
11
5
R01AD12
ATC
fluticasone furoate; nasal
3.1
7.9
49
221
XKD06
NOMESCO Finland
Physiologic investigation of micturition
9.9
7.8
15
17
A03CA02
ATC
clidinium and psycholeptics; oral
4.6
7.1
18
44
G44.2
ICD-10 Finland
Tension-type headache
3.5
6.9
27
91
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.0
6.9
40
172
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
6.7
64
357
G03CA04
ATC
estriol; systemic, vaginal
3.5
6.5
25
83
90621, ,
NOMESCO Finland
73.6
6.5
7
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
12.0
6.4
11
10
G04BD11
ATC
fesoterodine; oral
7.8
6.4
14
20
7362
FHL
Urethral dilatation in anesthesia or operating room
+∞
6.3
6
*
KCC00
NOMESCO Finland
Cystectomy
+∞
6.3
6
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.7
6.3
51
260
A02BA02
ATC
ranitidine; systemic
2.8
6.2
39
174
J01CA08
ATC
pivmecillinam; oral
2.8
6.2
83
539
H43.8
ICD-10 Finland
Other disorders of vitreous body
3.6
6.1
22
70
M13.9
ICD-10 Finland
Arthritis, unspecified
4.2
6.1
17
45
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
37
195
2.30
3.97
5.1
3.9
574.78
154.03
ng/l
0.69
27
160
46
284
2.00
3.21
9.2
4.4
0.00
0.00
estimate
-0.00
15
99
60
407
1.95
3.19
2.4
2.6
79.43
96.62
ug/l
0.65
55
373
9
20
4.77
3.18
2.9
2.9
—
—
—
0
0
5
6
8.62
2.77
1.4
1.8
—
—
—
0
0
5
6
8.62
2.77
1.4
1.8
—
—
—
0
0
5
6
8.62
2.77
1.4
1.8
—
—
—
0
0
53
358
1.86
2.76
5.8
3.1
—
—
—
0
0
29
159
2.09
2.75
6.0
2.8
3.58
3.70
e6/l
0.03
19
88
38
231
1.94
2.71
2.0
2.1
2.38
3.18
mg/l
1.33
33
203
9
25
3.80
2.63
2.6
1.5
—
—
—
0
0
6
11
5.67
2.57
1.7
2.5
—
—
—
0
0
13
51
2.74
2.54
7.2
3.8
25.28
24.90
mmol/l
0.17
13
51
9
27
3.52
2.45
2.0
1.1
—
—
—
0
0
27
151
2.02
2.42
2.0
3.1
0.84
0.80
mmol/l
0.97
27
134
10
35
3.02
2.27
1.4
1.5
—
—
—
0
0
68
516
1.73
2.26
8.0
4.3
0.00
0.00
estimate
-0.00
16
94
13
56
2.48
2.13
7.2
4.6
95.35
94.40
%
0.65
13
56
19
100
2.07
1.99
1.9
1.7
—
—
—
0
0
16
79
2.18
1.96
2.0
3.3
74.20
64.38
ml/min/173m2
—
5
39
65
512
1.59
1.70
9.0
5.9
0.00
0.00
estimate
-0.00
16
97
28
178
1.75
1.69
5.1
2.6
2.15
1.12
e6/l
0.30
18
105
13
63
2.19
1.67
1.1
1.2
37.92
169.66
iu/ml
—
6
28
5
14
3.68
1.63
1.4
1.5
—
—
—
0
0
5
14
3.68
1.63
1.4
1.5
—
—
—
0
0
65
516
1.57
1.62
8.2
4.3
0.00
0.00
estimate
-0.00
16
103
8
33
2.52
1.57
1.0
1.4
—
—
—
0
0
12
58
2.19
1.55
1.6
2.4
1.26
1.12
%
0.28
12
58
5
15
3.43
1.54
1.2
1.7
—
—
—
0
0
24
150
1.75
1.53
1.8
1.8
—
—
—
0
0
49
369
1.55
1.51
2.8
3.5
2.39
2.36
mmol/l
0.85
44
327
22
136
1.76
1.45
4.8
1.8
30.15
29.27
s
0.19
22
130
5
16
3.21
1.45
2.0
1.3
—
—
—
0
0
72
595
1.53
1.43
4.7
4.3
6.41
6.58
mmol/l
0.53
66
549
23
145
1.73
1.42
1.8
1.4
—
—
—
0
0
52
403
1.51
1.39
8.1
4.5
—
—
—
0
0
19
114
1.79
1.38
5.9
4.6
5.35
5.18
kpa
0.40
19
108
19
114
1.79
1.38
5.9
4.6
13.18
11.65
kpa
0.63
19
108
17
99
1.84
1.36
1.5
1.6
—
—
—
0
0
8
36
2.31
1.27
1.4
1.3
1.36
1.18
g/l
—
8
36
11
56
2.06
1.26
1.6
2.4
0.55
0.69
%
0.79
11
56
67
555
1.47
1.25
6.7
9.1
4.06
4.12
e9/l
0.07
61
492
17
102
1.78
1.24
2.1
2.3
5.40
7.74
umol/l
0.62
12
87
5
19
2.70
1.23
4.8
3.2
47.00
63.16
%
—
5
19
5
20
2.56
1.16
1.2
1.0
—
—
—
0
0
13
73
1.88
1.16
2.8
6.2
9.31
9.00
mmol/l
0.05
13
66
59
484
1.43
1.12
12.3
14.8
1.24
1.24
inr
0.02
25
147
27
189
1.55
1.12
1.3
1.4
—
—
—
0
0
5
21
2.44
1.10
1.2
1.5
—
—
—
0
0
12
68
1.85
1.05
1.4
1.8
—
—
—
0
0
5
22
2.33
1.04
1.2
1.5
—
—
—
0
0
7
35
2.06
1.02
1.4
1.3
0.27
0.23
g/l
—
7
35
10
54
1.93
1.00
1.8
3.2
48.35
43.31
%
—
10
54
0
28
0.00
0.99
0.0
1.3
—
361.95
—
0
15
31
230
1.47
0.99
1.4
1.2
0.59
1.92
u/ml
—
10
61
63
533
1.38
0.96
5.9
5.2
1.22
1.23
mmol/l
0.33
55
454
87
779
1.42
0.93
5.7
4.3
14.99
14.86
pmol/l
0.21
81
695
17
112
1.60
0.91
2.9
3.9
1.06
1.08
mmol/l
0.15
17
97
6
31
1.98
0.85
2.0
2.0
—
—
—
0
0
6
32
1.92
0.83
1.2
1.2
—
—
—
0
0
8
47
1.75
0.82
1.3
1.3
—
—
—
0
0
6
33
1.86
0.80
1.0
1.8
2.53
3.16
g/l
—
6
33
49
410
1.33
0.76
6.3
4.2
35.12
35.05
ng/l
0.00
29
290
9
56
1.66
0.74
1.9
3.4
24.34
25.03
mmol/l
—
9
56
34
273
1.34
0.69
2.5
3.5
1.07
6.34
mg/mmol
2.72
22
158
8
50
1.64
0.63
1.5
1.6
—
—
—
0
0
23
178
1.36
0.59
1.4
1.3
38.13
10.60
u/ml
—
10
72
6
36
1.70
0.57
1.2
1.5
—
—
—
0
0
6
37
1.65
0.56
1.0
1.7
7.12
7.89
g/l
—
6
37
6
37
1.65
0.56
1.0
1.7
—
—
—
0
0
6
37
1.65
0.56
1.0
1.7
3.40
3.73
g/l
—
6
37
6
40
1.53
0.52
2.0
1.9
—
—
—
0
0
50
438
1.24
0.51
2.3
2.0
111.38
98.04
pmol/l
0.76
18
206
83
887
0.79
0.51
4.5
4.1
1.47
1.23
mmol/l
1.09
78
803
23
183
1.32
0.50
1.5
1.3
17.60
43.05
iu/ml
—
5
65
5
31
1.64
0.43
3.8
2.2
—
—
—
0
0
5
33
1.54
0.42
1.4
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
88
926
0.81
0.39
5.5
4.6
4.62
4.70
mmol/l
0.30
82
850
31
265
1.23
0.39
1.5
1.5
24.36
21.30
nmol/l
0.40
25
219
14
108
1.34
0.37
4.3
4.0
—
—
—
0
0
15
118
1.31
0.35
20.5
7.0
—
—
—
0
0
88
837
1.19
0.32
23.8
17.5
14.32
15.17
%
1.22
88
823
5
38
1.33
0.23
2.2
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
6
49
1.24
0.20
1.2
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
6
50
1.21
0.20
1.2
1.3
—
—
—
0
0
5
65
0.76
0.17
1.0
1.7
—
—
—
0
0
93
955
0.88
0.17
6.1
5.1
2.70
2.72
mmol/l
0.07
86
872
91
935
0.89
0.17
5.6
4.6
5.85
5.89
mmol/l
0.19
86
857
8
72
1.12
0.16
1.8
2.2
—
—
—
0
0
7
87
0.79
0.15
2.3
5.7
1.99
2.77
ug/l
—
7
78
22
241
0.89
0.13
2.4
2.4
335.68
10961.11
umol/l
2.28
22
206
94
920
1.10
0.12
6.9
5.2
1.79
3.21
mu/l
0.55
89
836
7
66
1.06
0.08
1.7
1.9
—
—
—
0
0
54
557
0.94
0.08
3.2
2.8
—
—
—
0
0
46
447
1.05
0.05
2.5
2.4
—
—
—
0
0
99
979
1.06
0.05
21.5
15.0
19.02
21.48
mg/l
0.46
86
772
91
919
0.96
0.03
20.4
14.2
78.48
76.83
ml/min/173m2
0.30
80
750
104
1048
0.94
0.02
30.1
21.8
4.41
4.37
e12/l
0.38
99
1017
104
1048
0.94
0.02
29.8
21.7
39.43
39.19
%
0.18
99
988
23
223
1.04
0.01
1.7
1.8
496.11
480.57
pmol/l
0.08
18
182
101
1013
0.98
0.00
25.4
17.6
73.98
73.06
umol/l
0.16
101
1013
22
217
1.02
0.00
2.2
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
56.02
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
3.79
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
11.22
—
0
6
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
21.95
—
0
6
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.0
—
537.75
—
0
8
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
10.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
13.62
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: INTERSTITIAL_CYSTIT_CHRONIC – Interstitial cystitis (chronic), drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).